Cell-Cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors

Journal of Cellular Biochemistry

Volumn 112, Issue 7, 2011, Pages 1817-1821

  Achille, Valentina ^a   Mantelli, Melissa ^a   Arrigo, Giulia ^b   Novara, Francesca ^b   Avanzini, Maria Antonietta ^a   Bernardo, Maria Ester ^c   Zuffardi, Orsetta ^b   Barosi, Giovanni ^a   Zecca, Marco ^a   Maccario, Rita ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Cell cycle; Karyotype; Mesenchymal stromal cells

Indexed keywords

ARTICLE; BONE MARROW; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CHROMOSOME ANALYSIS; COMPARATIVE STUDY; HUMAN; IN VITRO STUDY; MESENCHYMAL STROMAL CELL; MESENCHYME CELL; METAPHASE; NORMAL HUMAN; PRIORITY JOURNAL; STROMA CELL;

BONE MARROW CELLS; CELL CYCLE; CELLS, CULTURED; CHROMOSOME BANDING; FLOW CYTOMETRY; GENOMIC INSTABILITY; HUMANS; KARYOTYPING; MESENCHYMAL STEM CELLS; STROMAL CELLS; TISSUE DONORS;

EID: 80051492988     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23100     Document Type: Article

References (19)

1. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584. (Pubitemid 38324589)
2. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F. 2007a. Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149. (Pubitemid 47535900)
3. Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, Del Fante C, Novara F, De Silvestri A, Amendola G, Zuffardi O, Maccario R, Locatelli F. 2007b. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute. J Cell Physiol 211:121-130. (Pubitemid 46363901)
4. Bernardo ME, Ball LM, Cometa AM, Roelofs H, Zecca M, Avanzini MA, Bertaina A, Vinti L, Lankester A, Maccario R, Ringden O, Le Blanc K, Egeler RM, Fibbe WE, Locatelli F. 2011. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 46:200-207.
5. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M. 2005. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human. Cancer Res 65: 3126-3135. (Pubitemid 40524593)
6. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. 2001. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402.
7. Da Silva ML, Chagastelles PC, Nardi NB. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213. (Pubitemid 43960310)
8. Dalton S. 2009. The molecular basis of embryonic stem cells self-renewal. Rajasekhar VK, Vemuri MC, editors. Regulatory networks in stem cells. Totowa, NJ: Humana Press. pp 3-12.
9. Davis PK, Ho A, Dowdy SF. 2001. Biological methods for cell-cycle synchronization of mammalian cells. BioTechniques 30(6):1322-1331. (Pubitemid 32523842)
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
11. Herrera RE, Chen F, Weinberg RA. 1996. Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts. Proc Natl Acad Sci 93:11510-11515. (Pubitemid 26347152)
12. Jorgensen C, Gordeladze J, Noel D. 2004. Tissue engeneering through autologus mesenchymal stem cells. Curr Opin Biotechnol 15:406-410. (Pubitemid 39304035)
13. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III. 2010. Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells Nov 18 [Epub ahead of print].
14. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O. 2008. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586. (Pubitemid 351626841)
15. Merrill GF. 1998. Cell synchronization. Methods Cell Biol 57:229-249. (Pubitemid 128787443)
16. Ohtsuka S, Dalton S. 2008. The biology of embryonic pluripotency. Gene Ther 15:74-81.
17. Singh AM, Dalton S. 2009. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5:141-149.
18. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebé L. 2010. Société Franĉaise de Greffe de Moelle et Thérapie Cellulaire. Clinical-grade production of human mesenchymal stromal cells: Occurrence of aneuploidy without transformation. Blood 115:1549-1553.
19. Wagner W, Ho AD, Zenke M. 2010. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16:445-453.